StockData
Elevance Health, Inc. logo

Elevance Health, Inc. (ELV) stock

ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3011% below fair value
$433.93−12.35 (-2.77%)

Close on Nov 17, 2026Market cap $93.75BP/E 18.5Yield –

Elevance Health cash

Cash and short-term investments held at the end of each period.

Elevance Health's cash was $35.70B at Sep 30, 2026. For fiscal 2025 it was $35.38B, up 5.6% from the year before. Over ten years it grew 6.4% a year on average. The highest annual figure on record is $36.14B in fiscal 2023.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$35.38B+5.6%
FY2024Dec 31, 2024$33.49B-7.3%
FY2023Dec 31, 2023$36.14B+8.4%
FY2022Dec 31, 2022$33.34B+7.0%
FY2021Dec 31, 2021$31.15B+6.8%
FY2020Dec 31, 2020$29.17B+18.5%
FY2019Dec 31, 2019$24.61B+19.3%
FY2018Dec 31, 2018$20.63B-1.7%
FY2017Dec 31, 2017$20.99B-1.2%
FY2016Dec 31, 2016$21.24B+11.6%
FY2015Dec 31, 2015$19.03B-3.0%
FY2014Dec 31, 2014$19.62B+5.4%
FY2013Dec 31, 2013$18.62B-4.0%
FY2012Dec 31, 2012$19.39B+7.0%
FY2011Dec 31, 2011$18.11B+1.4%
FY2010Dec 31, 2010$17.86B-12.9%
FY2009Dec 31, 2009$20.51B+447.2%
FY2008Dec 31, 2008$3.75B+35.4%
FY2007Dec 31, 2007$2.77B+6.4%
FY2006Dec 31, 2006$2.60B–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$35.70B+2.0%
Q2 FY2026Jun 30, 2026$35.95B+6.2%
Q1 FY2026Mar 31, 2026$35.56B+8.0%
Q4 FY2025Dec 31, 2025$35.38B+5.6%
Q3 FY2025Sep 30, 2025$35.00B-5.0%
Q2 FY2025Jun 30, 2025$33.86B-4.3%
Q1 FY2025Mar 31, 2025$32.94B-7.9%
Q4 FY2024Dec 31, 2024$33.49B-7.3%
Q3 FY2024Sep 30, 2024$36.82B-4.9%
Q2 FY2024Jun 30, 2024$35.40B-6.9%
Q1 FY2024Mar 31, 2024$35.76B-5.4%
Q4 FY2023Dec 31, 2023$36.14B+8.4%
Q3 FY2023Sep 30, 2023$38.73B+12.6%
Q2 FY2023Jun 30, 2023$38.01B+18.0%
Q1 FY2023Mar 31, 2023$37.78B+16.7%
Q4 FY2022Dec 31, 2022$33.34B+7.0%
Q3 FY2022Sep 30, 2022$34.40B+8.0%
Q2 FY2022Jun 30, 2022$32.22B+3.6%
Q1 FY2022Mar 31, 2022$32.38B-4.4%
Q4 FY2021Dec 31, 2021$31.15B+6.8%
Q3 FY2021Sep 30, 2021$31.84B+19.3%
Q2 FY2021Jun 30, 2021$31.11B+10.9%
Q1 FY2021Mar 31, 2021$33.88B+34.3%
Q4 FY2020Dec 31, 2020$29.17B+18.5%
Q3 FY2020Sep 30, 2020$26.69B+10.5%
Q2 FY2020Jun 30, 2020$28.05B+20.9%
Q1 FY2020Mar 31, 2020$25.23B+13.2%
Q4 FY2019Dec 31, 2019$24.61B+19.3%
Q3 FY2019Sep 30, 2019$24.15B+11.5%
Q2 FY2019Jun 30, 2019$23.20B+6.6%
Q1 FY2019Mar 31, 2019$22.28B+2.6%
Q4 FY2018Dec 31, 2018$20.63B-1.7%
Q3 FY2018Sep 30, 2018$21.65B-12.7%
Q2 FY2018Jun 30, 2018$21.76B-7.4%
Q1 FY2018Mar 31, 2018$21.72B-12.1%
Q4 FY2017Dec 31, 2017$20.99B-1.2%
Q3 FY2017Sep 30, 2017$24.79B–
Q2 FY2017Jun 30, 2017$23.51B–
Q1 FY2017Mar 31, 2017$24.72B–
Q4 FY2016Dec 31, 2016$21.24B–

More Elevance Health figures

See a number that looks wrong?